Virpax Pharmaceuticals, Inc. Business Finance Contracts & Agreements
23 Contracts & Agreements
- Note Agreements (15 contracts)
- Stock Agreements (4)
- Underwriting Agreements (2)
- Warrant Agreements (2)
- Virpax Pharmaceuticals, Inc. Form of Restricted Stock Unit Award Agreement (Filed With SEC on July 25, 2022)
- Virpax Pharmaceuticals, Inc. Form of Restricted Stock Award Agreement (Filed With SEC on July 25, 2022)
- Virpax Pharmaceuticals, Inc. Form of Nonqualified Stock Option Grant Agreement (Filed With SEC on July 25, 2022)
- Form of Underwriting Agreement (Filed With SEC on September 9, 2021)
- Form of Underwriters Warrant (Filed With SEC on February 2, 2021)
- Form of Underwriting Agreement (Filed With SEC on February 2, 2021)
- Short Term Note Agreement between Christopher Chipman and Virpax Pharmaceuticals, Inc., dated January 7, 2021 (Filed With SEC on January 8, 2021)
- Short Term Note Agreement between Anthony P. Mack and Virpax Pharmaceuticals, Inc., dated January7, 2021 (Filed With SEC on January 8, 2021)
- Fourth Amendment to the Services Convertible Promissory Note, dated as of December 31, 2020, between Virpax Pharmaceuticals, Inc. and RRD International, LLC (Filed With SEC on January 8, 2021)
- Third Amendment to the Services Convertible Promissory Note, dated as of November 30, 2020, between Virpax Pharmaceuticals, Inc. and RRD International, LLC (Filed With SEC on December 16, 2020)
- Service Provider Convertible Note Purchase Agreement, dated August 29, 2019, between Virpax Pharmaceuticals, Inc. and RRD International, LLC (Filed With SEC on December 16, 2020)
- Amendment No. 2 to the Promissory Note Dated January 15, 2019, dated October 28, 2020, between Anthony Mack and Virpax Pharmaceuticals, Inc (Filed With SEC on November 20, 2020)
- Amendment No. 2 to the Promissory Note Dated October 1, 2018, dated October 28, 2020, between Anthony Mack and Virpax Pharmaceuticals, Inc (Filed With SEC on November 20, 2020)
- Form of Consultant Warrant (Filed With SEC on October 9, 2020)
- Specimen Certificate representing shares of common stock of Virpax Pharmaceuticals, Inc (Filed With SEC on October 9, 2020)
- Promissory Note, dated October 1, 2018, between Anthony Mack and Virpax Pharmaceuticals, Inc (Filed With SEC on October 9, 2020)
- Amendment No. 1 to the Promissory Note Dated October 1, 2018, dated April 6, 2020, between Anthony Mack and Virpax Pharmaceuticals, Inc (Filed With SEC on October 9, 2020)
- Promissory Note, dated January 15, 2019, between Anthony Mack and Virpax Pharmaceuticals, Inc (Filed With SEC on October 9, 2020)
- Amendment No. 1 to the Promissory Note Dated January 15, 2019, dated April 6, 2020, between Anthony Mack and Virpax Pharmaceuticals, Inc (Filed With SEC on October 9, 2020)
- Service Provider Convertible Note Purchase Agreement, dated August 29, 2019, between Virpax Pharmaceuticals, Inc. and RRD International, LLC (Filed With SEC on October 9, 2020)
- First Amendment to the Services Convertible Promissory Note, dated March 25, 2020, between Virpax Pharmaceuticals, Inc. and RRD International, LLC (Filed With SEC on October 9, 2020)
- Second Amendment to the Services Convertible Promissory Note, dated as of September 30, 2020, between Virpax Pharmaceuticals, Inc. and RRD International, LLC (Filed With SEC on October 9, 2020)
- Paycheck Protection Program Term Note, dated May 4, 2020, between Virpax Pharmaceuticals, Inc. and PNC Bank, National Association (Filed With SEC on October 9, 2020)
